By Marisa Wong
Los Angeles, Dec. 24 – GS Finance Corp. priced $239,000 of 0% leveraged buffered notes due May 30, 2023 tied to the SPDR S&P Biotech exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by Goldman Sachs Group, Inc.
If the ETF finishes above its initial level, the payout at maturity will be par plus 2 times the gain, subject to a maximum payout of par plus 27%.
If the ETF finishes flat or falls by up to 10%, investors will receive par. Otherwise, investors will lose 1% for every 1% ETF decline beyond 10%.
Goldman Sachs & Co. LLC is the agent.
| Issuer: | GS Finance Corp.
|
| Guarantor: | Goldman Sachs Group, Inc.
|
| Issue: | Leveraged buffered notes
|
| Underlying ETF: | SPDR S&P Biotech ETF
|
| Amount: | $239,000
|
| Maturity: | May 30, 2023
|
| Coupon: | 0%
|
| Price: | Par
|
| Payout at maturity: | Par plus 2 times any ETF gain, capped at par plus 27%; par if ETF finishes flat or falls by up to 10%; otherwise, 1% loss for every 1% decline beyond 10%
|
| Initial value: | $126.06
|
| Pricing date: | Nov. 24
|
| Settlement date: | Nov. 30
|
| Agent: | Goldman Sachs & Co. LLC
|
| Fees: | 2.955%
|
| Cusip: | 40057EJS7
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
